×
For best experience we recommend to activate Javascript in your browser.
KAP1 antibody (AA 504-820)
This Rabbit Polyclonal antibody specifically detects KAP1 in WB, IHC, IP and ICC. It exhibits reactivity toward Mouse.
Quick Overview for KAP1 antibody (AA 504-820) (ABIN7628656)
Target
See all KAP1 (TRIM28) Antibodies
KAP1 (TRIM28)
(Tripartite Motif Containing 28 (TRIM28))
Reactivity
All reactivities for KAP1 antibodies
Mouse
Host
All hosts for KAP1 antibodies
Rabbit
Clonality
All clonalities for KAP1 antibodies
Polyclonal
Conjugate
All conjugates for KAP1 antibodies
This KAP1 antibody is un-conjugated
Application
All applications for KAP1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-KAP1 Antibody
(hide)
Binding Specificity
All epitopes for KAP1 antibodies
AA 504-820
Purpose
Transcriptional Intermediary Factor 1 Beta (TIF1b) Polyclonal Antibody
Sequence
Pro504~Ala820
Characteristics
The Transcriptional Intermediary Factor 1 Beta (TIF1b) Polyclonal Antibody (Species: Mouse) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for KAP1
(hide)
Target
KAP1 (TRIM28)
(Tripartite Motif Containing 28 (TRIM28))
Alternative Name
TIF1b
Gene ID
21849
UniProt
Q62318
Pathways
Hedgehog Signaling , Positive Regulation of Response to DNA Damage Stimulus
Recently viewed
(hide)
Chat with us , powered by LiveChat